
DeepMind's AlphaGenome maps the dark genome to disease clues
DeepMind's AlphaGenome is a sequence-to-function AI that can scan up to one million DNA letters at once to map the dark genome, predict how mutations affect gene expression and splicing, and flag disease-linked variants and potential drug targets, offering a major advance for obesity, diabetes, cancer, and other conditions—though it's still imperfect and will require refinement.













